Imbruvica (ibrutinib) is an oral cancer medication used for certain leukemias, blood cancers, and blood cell conditions. It commonly causes diarrhea, tiredness, and easy bruising.
Chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) in adults
Waldenström's macroglobulinemia (WM) in adults
Chronic graft versus host disease (cGVHD) in adults and children 1 year and older
Imbruvica (ibrutinib) is a kinase inhibitor. It blocks a protein in your body to help stop cancer cells from growing and multiplying.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Oral medication
Once-daily dosing
One of the first-choice treatment options for CLL
Safe to use in people with mild kidney problems; no dose adjustments needed
Raises your risk for infections and serious bleeding events
Must use birth control while taking, as it can harm an unborn baby
Not a good option in people with severe liver problems
Available as brand only, so it can be expensive
Swallow Imbruvica (ibrutinib) capsules or tablets whole with a glass of water with or without food. Don't open, break, cut, crush, or chew the capsules or tablets.
If using Imbruvica (ibrutinib) oral suspension, review the instructions for use to make sure you give the right dose to your child. Ask your child's provider if you have any further questions. Don't use it if the seal on the carton is broken or missing.
Drink plenty of fluids to stay hydrated while taking Imbruvica (ibrutinib). A common side effect of this medication is diarrhea, which can lead to dehydration and raise your risk of serious complications.
Follow up with your provider for monthly blood tests. Imbruvica (ibrutinib) can cause your blood cell counts to drop, so your provider will check these measurements to make sure they don't go too low.
If you miss a dose of Imbruvica (ibrutinib), take it as soon as you remember that same day. Then take your next dose at your regularly scheduled time the next day. Never double up to make up for a missed dose since this could lead to side effects.
Avoid grapefruit, Seville oranges (commonly found in marmalades), and their juices. These foods can interact with Imbruvica (ibrutinib), raise the medication levels in your body, and raise your risk of side effects.
Give your care team your most up-to-date list of medications and talk to them before starting any new medications, including prescription medications, over-the-counter products, and herbal supplements. Since Imbruvica (ibrutinib) can interact with many medications, your providers will need to make sure all your medications are safe for you to take. This might require dose adjustments to your medications, including Imbruvica (ibrutinib).
Imbruvica (ibrutinib) shouldn't be used in pregnancy, since it can harm an unborn baby. Whether you're a female or male taking this medication, if you or your partner is of childbearing age, use reliable birth control during treatment and for 1 month after stopping the medication. Your partner can also use birth control during this time for extra precaution.
Imbruvica (ibrutinib) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Taking antiplatelet medications or blood thinners | Recent surgery
Imbruvica (ibrutinib) can cause many different bleeding-related side effects that can be serious. Bruising and red spots on the skin are most common, but serious brain and stomach bleeds have also been reported. The risk of major bleeding is higher if you're also taking antiplatelet medications or blood thinners. The risk for a serious bleed after surgery is also higher, so let your provider know if you have a procedure scheduled. They might tell you to stop your medication for a few days before and after your surgery. Contact your provider or get medical help right away if you experience blood in your vomit, urine, or stool, or a sudden and severe headache.
Some people taking Imbruvica (ibrutinib) have had serious, and sometimes fatal, infections. Wash your hands well with soap and warm water often to protect yourself from infections. Make sure to report any signs of an illness, especially fever and chills. If your risk for an infection is high, your provider might prescribe preventative medication.
Risk factors: High blood pressure | Infection | History of irregular heart beat
Rarely, serious heart conditions, like abnormal heart rhythms and heart failure, have occurred in some people taking Imbruvica (ibrutinib). Make sure your provider knows your full medical history. They might monitor you more closely if you have a history of heart conditions or have ever had an irregular heart beat. Contact your provider right away if you ever faint, or have a fast heart beat, lightheadedness, chest pain, or sudden shortness of breath.
About 20% of people in clinical studies taking Imbruvica (ibrutinib) had high blood pressure. Make sure you go to your regularly scheduled clinic visits so your provider can monitor your blood pressure. If your blood pressure starts to rise, your provider can prescribe blood pressure-lowering medications for you.
Sometimes, Imbruvica (ibrutinib) can raise your risk for developing other cancers. The most common type of cancer was non-melanoma skin cancer. Wear protective clothing and sunscreen if you're going to be under direct sunlight.
Risk factors: Higher tumor burden | Dehydration | Kidney damage
Rarely, Imbruvica (ibrutinib) causes tumor lysis syndrome, a condition that can be dangerous if not treated right away. This is more likely if you have a lot of cancerous cells (high tumor burden), are dehydrated, or have kidney damage. Talk to your provider right away if you experience dark urine, a racing heart, muscle cramps or spasms, numbness, nausea, or vomiting within the first week of taking Imbruvica (ibrutinib). You'll need to get appropriate care to prevent complications.
The typical dose is 420 mg by mouth once daily.
Your dose might differ if you have liver problems or are also taking certain medications that can interact with Imbruvica (ibrutinib).
Chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) in adults
Waldenström's macroglobulinemia (WM) in adults
Chronic graft versus host disease (cGVHD) in adults and children 1 year and older
Chronic lymphocytic leukemia (CLL)
Hodgkin’s lymphoma (HL)
Other non-Hodgkin’s lymphomas
Certain types of CD20-positive non-Hodgkin’s lymphoma (NHL) in adults and children ages 6 months and older
CD20-positive chronic lymphocytic leukemia (CLL) in adults
Moderate to severe rheumatoid arthritis (RA) in adults
Granulomatosis with polyangitis (GPA) and microscopic polyangitis (MPA) in adults and children ages 2 years and older
Moderate to severe pemphigus vulgaris in adults
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.